Forte Biosciences Q2 EPS $(0.42) Down From $(0.21) YoY
Portfolio Pulse from Benzinga Newsdesk
Forte Biosciences (NASDAQ:FBRX) reported a 100% increase in its Q2 losses year-over-year, with losses of $(0.42) per share compared to $(0.21) per share in the same period last year.
August 14, 2023 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Forte Biosciences reported a significant increase in its Q2 losses, which could negatively impact investor sentiment.
Forte Biosciences' reported losses have doubled compared to the same period last year. This indicates a worsening financial situation, which could lead to a decrease in the company's stock price as investors may see this as a negative sign.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100